Ocrelizumab (anti-CD20)
98%
- Product Code: 128563
CAS:
637334-45-3
| Molecular Weight: | Molecular Formula: | ||
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in the treatment of multiple sclerosis, particularly relapsing forms and primary progressive MS. It targets CD20-positive B cells, reducing immune-mediated damage to the central nervous system. Administered intravenously, it helps slow disease progression, reduce relapse rates, and limit new lesion formation on MRI. Also investigated for other autoimmune conditions involving B cells.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿73,990.00 |
+
-
|
Ocrelizumab (anti-CD20)
Used in the treatment of multiple sclerosis, particularly relapsing forms and primary progressive MS. It targets CD20-positive B cells, reducing immune-mediated damage to the central nervous system. Administered intravenously, it helps slow disease progression, reduce relapse rates, and limit new lesion formation on MRI. Also investigated for other autoimmune conditions involving B cells.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :